Common Stock, Shares, Outstanding of Cadrenal Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cadrenal Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Cadrenal Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 2,059,754, a 67% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cadrenal Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 2,059,754 +825,082 +67% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 2,007,113 -14,001,356 -87% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 1,909,732 -14,098,737 -88% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 1,782,486 +914,302 +105% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 1,234,672 -11,788,082 -91% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 16,008,469 +4,285,715 +37% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 16,008,469 +4,285,715 +37% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 868,184 -7,325,691 -89% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 13,022,754 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 11,722,754 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 11,722,754 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 8,193,875 31 Dec 2022 10-K 11 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.